The availability of advanced medications has opened up new avenues for patients seeking relief from their symptoms. This is especially true in the realm of chronic obstructive pulmonary disease management.
Two prominent contenders in this field are Breztri and Trelegy. Both of which offer triple therapy approaches through inhalers.
These medications combine different active ingredients. In this article, we will discuss the advantages and potential drawbacks of these treatments. We’ll do this by comparing Breztri vs Trelegy.
So, read on!
Triple Therapy
Breztri and Trelegy are two commonly prescribed triple therapies for chronic obstructive pulmonary disease. Breztri is a combination of three different drugs:
- umeclidinium
- vilanterol
- fluticasone furoate
These are meant to open up airways and reduce inflammation in the lungs. While effective, it can cause throat irritation and mild headaches upon first use or if you fail to gargle right away after inhaling.
Trelegy is another triple therapy using the same prescription medications but with an added LABA. This is known as glycopyrronium bromide, which works to open up constricted airways and reduce mucus build-up.
While helpful to many, Trelegy can also cause:
- dizziness
- sore throat
- dry mouth
Both Breztri and Trelegy are effective triple therapies for COPD, but each comes with its pros and cons, so it’s important to discuss with your medical provider which one is best for you and how to properly use it.
Symptom Control
Both medications provide proper symptom control. However, Breztri may be more effective in preventing COPD exacerbations than Trelegy. Trelegy also has the added advantage of having a similar safety profile as the combination bronchodilator therapies it is replacing.
On the other hand, Breztri has no known drug interactions and is associated with fewer COPD symptoms and exacerbations, making it a better choice for patients with severe COPD.
Maintenance and Prevention
Breztri helps prevent flare-ups by bringing down the level of inflammation in the body and is taken daily. This treatment has the advantage of being effective immediately.
This is because it starts to work immediately when taken. However, Breztri can cause increased heart rates and palpitations, which can be very dangerous.
Trelegy, on the other hand, is a combination of three drugs:
- an inhaled corticosteroid
- a long-acting beta-agonist
- a long-acting muscarinic antagonist
Its advantage lies in providing a comprehensive and long-lasting prevention for COPD sufferers. It can also reduce exacerbations, meaning that flare-ups become less frequent and severe when taking the treatment.
Overall, both treatments are effective in preventing and managing COPD, and it is important to consult with your doctor about your specific needs to decide on the appropriate treatment for you.
Cost Comparison
When it comes to cost comparison, Breztri tends to be more expensive than Trelegy due to its advanced technology. While the cost of Trelegy is often cheaper, it may not be as effective in reducing COPD symptoms as Breztri.
Patients should consult with their physicians about which product is best suited to their condition and budget. Additionally, many benefits, such as Breztri coupons, discounts, and rebates, can be found through online programs, making medication more affordable for those in need.
Know the Differences Between Breztri vs Trelegy
The decision between Breztri vs Trelegy requires an individual to evaluate the pros and cons of each option. Each has its benefits and drawbacks. So understanding these gives an individual the information needed to make the best decision for their health.
Make sure to consult with your healthcare provider to decide which is the best choice for you.
Should you wish to explore more topics aside from these types of medication, visit our blog. We’ve got more!
Also read:
